Asthma and allergic rhinitis
Conditions
Interventions
Experimental group:Bifidobacterium infantile CFM1192
Sponsors
The People's Hospital of Tinghu, Yancheng City
Eligibility
Sex/Gender
All
Age
4 Years to 50 Years
Inclusion criteria
Inclusion criteria: 1.Consistent with the diagnosis of respiratory allergy; 2.Aged 3 to 14 years, male or female; 3.Good compliance, able to comply with the requirements of clinical trials; 4.Before treatment, blood, urine and stool routine, liver and kidney function tests were within the normal range; 5.The patient was willing to sign the informed consent form and could be followed up.
Exclusion criteria
Exclusion criteria: 1.Known to be allergic or intolerant to any ingredient in the experimental probiotic product; 2.Patients who had received systemic glucocorticoid treatment within 1 week before the test, or patients with systemic treatment (immunosuppressant, cell growth inhibitor); 3.Immunosuppressive patients (such as lymphoma) or patients with a history of malignant diseases complicated with any disease that interferes with the evaluation of test results; 4.Pregnant or lactating women; 5.Frequently take probiotic products or eat yogurt and probiotic drinks for a long time in the near future (within 1 month); 6.Recent (within 1 month) or long-term use of antibiotics.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Base data;Bronchial asthma;Fecal flora;Allergic rhinitis;Immunoassay;Bacteria detection; | — |
Countries
China
Contacts
Public ContactLu Wenwei
Jiangnan University
Outcome results
None listed